相关实验视频

Updated: Aug 3, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

11.5K

随着时间的推移,变化的表型和临床结果在微观多炎中发生了变化

Martina Uzzo1,2, Umberto Maggiore3, Filippo Sala1,4

  • 1Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.

Kidney international reports
|October 18, 2023
PubMed
概括

最近诊断的微观多炎 (MPA) 患者表现出不太严重的病和末期病 (ESKD) 的风险降低. 然而,MPA复发的风险增加了,而死亡风险仍然相当.

关键词:
抗中性细胞细胞体自抗体抗中性细胞体自抗体.一个半月状的丸隆炎.死亡死亡死亡死亡死亡死亡最终阶段的脏疾病.微观的多晶体炎.血管炎是一种血管炎.

更多相关视频

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

1.1K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.0K

相关概念视频

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...